Checkpoint Therapeutics (FRA:CZTA) Beginning Cash Position : €6.11 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Checkpoint Therapeutics Beginning Cash Position?

Checkpoint Therapeutics's Beginning Cash Position for the quarter that ended in Mar. 2025 was €6.11 Mil.

Checkpoint Therapeutics's quarterly Beginning Cash Position increased from Sep. 2024 (€4.46 Mil) to Dec. 2024 (€4.49 Mil) and increased from Dec. 2024 (€4.49 Mil) to Mar. 2025 (€6.11 Mil).

Checkpoint Therapeutics's annual Beginning Cash Position declined from Dec. 2022 (€51.67 Mil) to Dec. 2023 (€11.07 Mil) and declined from Dec. 2023 (€11.07 Mil) to Dec. 2024 (€4.71 Mil).

Checkpoint Therapeutics Beginning Cash Position Historical Data

The historical data trend for Checkpoint Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Checkpoint Therapeutics Beginning Cash Position Chart

Checkpoint Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

21.44

36.08

51.67

11.07

4.71

Checkpoint Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Beginning Cash Position	Get a 7-Day Free Trial															4.53	10.44	4.46	4.49	6.11

Checkpoint Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Checkpoint Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Checkpoint Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Checkpoint Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Checkpoint Therapeutics Inc (FRA:CZTA) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

CKPT:USA CZTA:Germany

Address

95 Sawyer Road, Suite 110, Waltham, MA, USA, 02453

Website

https://www.checkpointtx.com

Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.

Checkpoint Therapeutics Headlines

No Headlines